Literature DB >> 10931926

Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.

A W Hsu1, A F Kilani, K Liou, J Lee, F Liu.   

Abstract

RNase P from Escherichia coli is a tRNA-processing enzyme and consists of a catalytic RNA subunit (M1 RNA) and a protein component (C5 protein). M1GS, a gene-targeting ribozyme derived from M1, can cleave a herpes simplex virus 1 mRNA efficiently in vitro and inhibit its expression effectively in viral-infected cells. In this study, the effects of C5 on the interactions between a M1GS ribozyme and a model mRNA substrate were investigated by site-specific UV crosslink mapping. In the presence of the protein cofactor, the ribozyme regions crosslinked to the substrate sequence 3' immediately to the cleavage site were similar to those found in the absence of C5. Meanwhile, some of the ribozyme regions (e.g. P12 and J11/12) that were crosslinked to the leader sequence 5' immediately to the cleavage site in the presence of C5 were different from those regions (e.g. P3 and P4) found in the absence of the protein cofactor and were not among those that are believed to interact with a tRNA. Understanding how C5 affects the specific interactions between the ribozyme and its target mRNA may facilitate the development of gene-targeting ribozymes that function effectively in vivo, in the presence of cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931926      PMCID: PMC108434          DOI: 10.1093/nar/28.16.3105

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  The track of the pre-tRNA 5' leader in the ribonuclease P ribozyme-substrate complex.

Authors:  E L Christian; M E Harris
Journal:  Biochemistry       Date:  1999-09-28       Impact factor: 3.162

2.  Comparative analysis of ribonuclease P RNA structure in Archaea.

Authors:  E S Haas; D W Armbruster; B M Vucson; C J Daniels; J W Brown
Journal:  Nucleic Acids Res       Date:  1996-04-01       Impact factor: 16.971

3.  Probing of tertiary interactions in RNA: 2'-hydroxyl-base contacts between the RNase P RNA and pre-tRNA.

Authors:  T Pan; A Loria; K Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

Review 4.  Antiviral and anticancer ribozymes.

Authors:  E Poeschla; F Wong-Staal
Journal:  Curr Opin Oncol       Date:  1994-11       Impact factor: 3.645

5.  The yeast KEM1 gene encodes a nuclease specific for G4 tetraplex DNA: implication of in vivo functions for this novel DNA structure.

Authors:  Z Liu; W Gilbert
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

6.  Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  F Liu; S Altman
Journal:  Genes Dev       Date:  1995-02-15       Impact factor: 11.361

7.  Phylogenetic comparative chemical footprint analysis of the interaction between ribonuclease P RNA and tRNA.

Authors:  T E LaGrandeur; A Hüttenhofer; H F Noller; N R Pace
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

8.  Use of photoaffinity crosslinking and molecular modeling to analyze the global architecture of ribonuclease P RNA.

Authors:  M E Harris; J M Nolan; A Malhotra; J W Brown; S C Harvey; N R Pace
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

9.  Base pairing between Escherichia coli RNase P RNA and its substrate.

Authors:  L A Kirsebom; S G Svärd
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

10.  Rp-phosphorothioate modifications in RNase P RNA that interfere with tRNA binding.

Authors:  W D Hardt; J M Warnecke; V A Erdmann; R K Hartmann
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  1 in total

1.  Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.

Authors:  P Trang; J Lee; A F Kilani; J Kim; F Liu
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.